Labcyte Signs Bioscreen Instruments as Exclusive Distributor in India
Labcyte announced the selection of Bioscreen Instruments Pvt. Ltd. as its exclusive distributor in India.
“Bioscreen is a leading distributor in India. They will be a great partner for us,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc. “As we continue to expand throughout Asia, Bioscreen will help us further broaden our existing user base in the pharmaceutical industry and the contract research organizations (CROs) that service them, Bioscreen will provide them with industry-leading Labcyte acoustic technology for compound management, high-throughput and secondary screening. Bioscreen will give our new customers in India immediate support and interaction.
“We are extremely pleased to be the Labcyte partner in India. It is a great recognition of our distributor capabilities across the entire country of India. Labcyte products will allow us to provide our customers with state-of-the-art platform technology so that they can excel in their efforts,” said Mr. S. Radha Krishnan, Managing Director of Bioscreen Instruments. “We see a great potential market for low-volume liquid handlers in India. We believe that the miniaturization capabilities provided by Labcyte technology will be especially useful for the growing genomics markets, especially for gene expression, SNP analysis and RNAi.”
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Innovative technology for the enrichment of free-circulating DNA
Sex-determination_system
Bioxyne reports the results from the Phase IIb COPD study
Fundus_(uterus)
Angiogenesis_inhibitor
New insights into the ribosome - Investigators adapt a mass-spectrometry-based method to profile ribsomes and associated factors

Detailed structure of cell’s garbage disposal unit reveals surprise in how it is targeted by cancer drugs - Every atom counts

Genomic Stability: A Double-Edged Sword for Sharks - Sharks have long been said to have an exceptionally low cancer rate
Amylase
Ovacome
